Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY.
Fleseriu M, Führer-Sakel D, van der Lely AJ, De Marinis L, Brue T, van der Lans-Bussemaker J, Hey-Hadavi J, Camacho-Hubner C, Wajnrajch MP, Valluri SR, Palladino AA, Gomez R, Salvatori R. Fleseriu M, et al. Eur J Endocrinol. 2021 Aug 27;185(4):525-538. doi: 10.1530/EJE-21-0239. Eur J Endocrinol. 2021. PMID: 34342594 Free PMC article.
[Thyroid diseases and pregnancy].
Karger S, Führer-Sakel D. Karger S, et al. Med Klin (Munich). 2009 Jun 15;104(6):450-6. doi: 10.1007/s00063-009-1094-7. Epub 2009 Jun 16. Med Klin (Munich). 2009. PMID: 19533052 Review. German.
From first symptoms to final diagnosis of Cushing's disease: experiences of 176 patients.
Kreitschmann-Andermahr I, Psaras T, Tsiogka M, Starz D, Kleist B, Siegel S, Milian M, Kohlmann J, Menzel C, Führer-Sakel D, Honegger J, Sure U, Müller O, Buchfelder M. Kreitschmann-Andermahr I, et al. Eur J Endocrinol. 2015 Mar;172(3):285-9. doi: 10.1530/EJE-14-0766. Epub 2014 Dec 10. Eur J Endocrinol. 2015. PMID: 25501963
The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis.
Xu Y, Derakhshan A, Hysaj O, Wildisen L, Ittermann T, Pingitore A, Abolhassani N, Medici M, Kiemeney LALM, Riksen NP, Dullaart RPF, Trompet S, Dörr M, Brown SJ, Schmidt B, Führer-Sakel D, Vanderpump MPJ, Muendlein A, Drexel H, Fink HA, Ikram MK, Kavousi M, Rhee CM, Bensenor IM, Azizi F, Hankey GJ, Iacoviello M, Imaizumi M, Ceresini G, Ferrucci L, Sgarbi JA, Bauer DC, Wareham N, Boelaert K, Bakker SJL, Jukema JW, Vaes B, Iervasi G, Yeap BB, Westendorp RGJ, Korevaar TIM, Völzke H, Razvi S, Gussekloo J, Walsh JP, Cappola AR, Rodondi N, Peeters RP, Chaker L; Thyroid Studies Collaboration. Xu Y, et al. Among authors: fuhrer sakel d. Lancet Diabetes Endocrinol. 2023 Oct;11(10):743-754. doi: 10.1016/S2213-8587(23)00227-9. Epub 2023 Sep 8. Lancet Diabetes Endocrinol. 2023. PMID: 37696273
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study.
Douglas RS, Kahaly GJ, Ugradar S, Elflein H, Ponto KA, Fowler BT, Dailey R, Harris GJ, Schiffman J, Tang R, Wester S, Jain AP, Marcocci C, Marinò M, Antonelli A, Eckstein A, Führer-Sakel D, Salvi M, Sile S, Francis-Sedlak M, Holt RJ, Smith TJ. Douglas RS, et al. Ophthalmology. 2022 Apr;129(4):438-449. doi: 10.1016/j.ophtha.2021.10.017. Epub 2021 Oct 21. Ophthalmology. 2022. PMID: 34688699 Free article. Clinical Trial.
Meal replacement by formula diet reduces weight more than a lifestyle intervention alone in patients with overweight or obesity and accompanied cardiovascular risk factors-the ACOORH trial.
Halle M, Röhling M, Banzer W, Braumann KM, Kempf K, McCarthy D, Schaller N, Predel HG, Scholze J, Führer-Sakel D, Toplak H, Berg A; ACOORH study group. Halle M, et al. Eur J Clin Nutr. 2021 Apr;75(4):661-669. doi: 10.1038/s41430-020-00783-4. Epub 2020 Oct 30. Eur J Clin Nutr. 2021. PMID: 33128036 Clinical Trial.
46 results